New York, New York-- (Newsfile Corp. - April 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential ...

New York, New York-- (Newsfile Corp. - April 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential ...

DelveInsight's "ENTYVIO Market Size, Forecast, and Market Insight Report" highlights the details around ENTYVIO, a gut-selective ...

Teva Pharmaceutical Industries Limited (TEVA)’s share was trading at $13.94 as of April 7th. TEVA’s trailing and forward P/E were 872 and 5.37 respectively according to Yahoo Finance. After ...

Get the next trade alert free. Beam Therapeutics Inc. BEAM on Saturday presented additional data from the Phase 1/2 clinical trial of BEAM-302 in patients with alpha-1 antitrypsin deficiency (AATD ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a ...

NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept Therapeutics ... August 2020, Teva Pharmaceutical Industries ...

TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2025 Aide Memoire is available on the “Investors ...

The Motley Fool has positions in and recommends Merck and Summit Therapeutics. The Motley Fool has a disclosure policy. 2 Stocks That Have More Than Doubled in the Past Year to Buy and Hold for a ...

Summit Therapeutics (NASDAQ:SMMT) traded higher in the premarket on Wednesday after Citi upgraded the stock to Buy from Neutral, becoming the latest brokerage to issue a bullish view on the cancer ...

A source familiar with the situation told the Business Journal that the executive team and board of directors at Lyndra Therapeutics resigned on Tuesday. Lyndra Therapeutics, a drug developer that ...

NYSE:TEVA opened at $16.18 on Wednesday. The company has a 50-day moving average of $17.79 and a 200-day moving average of $18.21. The firm has a market cap of $18.34 billion, a price-to-earnings ...